Intervacc Presents Results of New Study – Their Vaccine Strangvac(R) Protects Horses Against Strangles Even at a Low Dose

STOCKHOLM, Sweden--(BUSINESS WIRE)--Intervacc recently completed a study where the primary goals were to establish a suitable level of antigens in Strangvac and to assess the efficacy after two intramuscular immunisations.